Chemours (CC)
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-04
$15.30-1.16%
Close 2026-09-04 · 1-day change
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-04
QuarterlyIQ Insights · CC
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||
| Revenues | 5,796.0 | 5,808.0 | 5,782.0 | 6,078.0 | 6,831.0 | 6,345.0 | 4,969.0 | 5,526.0 | 6,638.0 | 6,183.0 | 5,400.0 | 5,717.0 |
| Total Revenues | — | — | — | — | — | — | — | — | 6,638.0 | 6,183.0 | 5,400.0 | 5,717.0 |
| Cost of Revenues | 4,910.0 | 4,906.0 | 4,631.0 | 4,776.0 | 5,215.0 | 4,964.0 | 3,902.0 | 4,463.0 | 4,667.0 | — | — | — |
| Gross Profit | 886.0 | 902.0 | 1,151.0 | 1,302.0 | 1,616.0 | 1,381.0 | 1,067.0 | 1,063.0 | 1,971.0 | 1,745.0 | 1,103.0 | 955.0 |
| Operating Expenses & Income | ||||||||||||
| Selling, General & Admin | 855.0 | 799.0 | 585.0 | 1,286.0 | 710.0 | 592.0 | 527.0 | 548.0 | 657.0 | 626.0 | 946.0 | 632.0 |
| R&D Expenses | 106.0 | 108.0 | 109.0 | 108.0 | 118.0 | 107.0 | 93.0 | 80.0 | 82.0 | 81.0 | 81.0 | 97.0 |
| Operating Income | — | — | — | (318.0) | 741.0 | 676.0 | 179.0 | (124.0) | 1,155.0 | 912.0 | (11.0) | (188.0) |
| Earnings from Continuing Operations | ||||||||||||
| Interest Expense | 273.0 | 269.0 | 264.0 | 208.0 | 163.0 | 185.0 | 210.0 | 208.0 | 195.0 | 214.0 | 219.0 | 132.0 |
| Asset Writedown | — | 24.0 | 27.0 | 97.0 | 5.0 | 0.0 | 22.0 | 43.0 | 4.0 | 1.0 | 119.0 | 45.0 |
| EBT, Incl. Unusual Items | (39.0) | (277.0) | 127.0 | (318.0) | 741.0 | 676.0 | 179.0 | (124.0) | 1,155.0 | 912.0 | (11.0) | (188.0) |
| Income Tax Expense | 252.0 | 109.0 | 41.0 | (66.0) | 163.0 | 68.0 | (40.0) | (72.0) | 159.0 | 165.0 | (18.0) | (98.0) |
| Net Income | ||||||||||||
| Minority Interest | — | — | — | 1.0 | — | — | 0.0 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 |
| Net Income | (290.0) | (386.0) | 86.0 | (253.0) | 578.0 | 608.0 | 219.0 | (52.0) | 995.0 | 746.0 | 7.0 | (90.0) |
| Per Share | ||||||||||||
| Basic EPS | (1.92) | (2.57) | 0.58 | (1.70) | 3.72 | 3.69 | 1.33 | (0.32) | 5.62 | 4.04 | 0.04 | (0.50) |
| Diluted EPS | (1.92) | (2.57) | 0.57 | (1.70) | 3.65 | 3.60 | 1.32 | (0.32) | 5.45 | 3.91 | 0.04 | (0.50) |
| Revenue per Share | 38.33 | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | — | 0.51 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | — | — | — | — |
| Basic Weighted Avg Shares | 151.2 | 150.2 | 149.5 | 148.9 | 155.4 | 164.9 | 164.7 | 164.8 | 177.0 | 184.8 | 181.6 | 181.0 |
| Diluted Weighted Avg Shares | 151.2 | 150.2 | 150.2 | 148.9 | 158.3 | 168.7 | 166.3 | 164.8 | 182.6 | 191.0 | 183.4 | 181.0 |
| Supplemental | ||||||||||||
| EBITDA | — | — | — | (9.0) | 1,032.0 | 993.0 | 499.0 | 187.0 | 1,439.0 | 1,185.0 | 273.0 | 79.0 |
| EBIT | — | — | — | (318.0) | 741.0 | 676.0 | 179.0 | (124.0) | 1,155.0 | 912.0 | (11.0) | (188.0) |
| Effective Tax Rate | -646.2% | — | — | 20.8% | 22.0% | 10.1% | -22.3% | 58.1% | 13.8% | 18.1% | 163.6% | 52.1% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.